Back to Directory
Last Updated: 09/05/2026
Stembond Technologies
Cambridge
Founded 2021
Biomimetic cell culture platform for reproducible cell therapy development
Stembond Technologies is a Cambridge University spin-out developing a synthetic, mechanically tuned biomimetic substrate that replicates the physical properties of human tissue microenvironments.
The platform delivers reproducible cell culture conditions, reducing phenotypic drift and improving consistency across cell-based workflows.
Stembond's technology supports culture of T cells, mesenchymal stem cells, haematopoietic stem cells, and iPSC-derived populations, serving academic research groups and cell therapy developers working toward scalable therapeutic manufacturing.